Molecules 2019, 24, 590
10 of 14
(d, J = 8.5 Hz, 1H), 11.32 (br s, 1H, –OH). 13C NMR (ppm/
δ
, 100 MHz, CDCl3)
δ
26.24, 52.74, 61.24,
66.52, 116.07, 120.23, 129.20, 129.75, 130.56, 162.43, 196.77. EIMS, m/z (% rel. intensity): 235(100) [M+,
C13H17NO3], 204 (16), 188 (38), 176 (12), 162 (20), 149 (76), 133 (18), 106 (10), 100 (10), 86 (45), 77 (21),
57 (22).
3.1.2. 1-{4-Hydroxy-3,5-bis[(morpholin-4-yl) methyl]phenyl}ethan-1-one (2b)
The purification of the crude product which has been synthesized in the respective ratio of
1:2:2 of compound
1, formaldehyde, and morpholine was done using column chromatography with
EtOAc/MeOH (9:1) as eluent to yield 2b as colorless needles (5.32 g; quantitative yield) mp 88–90 ◦C
after removing the solvent. IR spectrum (
ν
max/cm−1): 1113 (C–N), 1304 (C–O), 1597(C=C), 1669(C=O),
1
2958 (CH3, sp3). H NMR (ppm/
δ, 400 MHz, MeOD): 2.59–2.55 (m, 11H), 3.74–3.72 (m, 12H), 7.83 (s,
2H), 7.92 (s, 1H). 13C NMR (ppm/
δ, 100 MHz, MeOD): 24.90, 52.78, 58.18, 66.32, 121.97, 128.25, 130.24,
161.44, 197.94. EIMS, m/z (% rel. intensity): 334(14) [M+, C18H26N2O4], 276 (6), 247 (100), 217 (12), 189
(14), 162 (8), 133 (34), 119 (11), 86 (24), 56 (14).
3.1.3. 1-{4-Hydroxy-3-[(pyrrolidin-1-yl) methyl]phenyl}ethan-1-one (3a)
A ratio of 1:1.5:1.5 of compound 1, formaldehyde, and pyrrolidine, respectively, were used to
synthesize 3a. Eluting system of hexanes/EtOAc (6:4), was used to purify the crude product to yield
pale-yellow crystals, (1.72 g; 49%), mp 92–95 ◦C. IR spectrum (
ν
max/cm−1): 1191 (C–N), 1284 (C–O),
1
1595 (C=C), 1661 (C=O), 2965 (CH3, sp3). H NMR (ppm/
δ
, 400 MHz, MeOD): 1.99–1.94 (m, 4H), 2.51
(s, 3H), 2.92 (t, J = 7.0 Hz, 4H), 4.03 (s, 2H), 6.72 (d, J = 8.5 Hz, 1H), 7.79 (d, J = 2.3 Hz, 1H), 7.83 (dd,
J = 8.7 and 2.4 Hz, 1H). 13C NMR (ppm/
δ, 100 MHz, MeOD): 23.02, 24.67, 52.88, 57.13, 116.53, 121.21,
126.14, 130.22, 130.73, 167.15, 197.75. EIMS, m/z (% rel. intensity): 219 (13) [M+, C13H17NO2], 149 (5),
133 (3), 106 (2), 91 (2), 84 (9), 77 (4), 70(100), 51 (2).
3.1.4. 1-{4-Hydroxy-3,5-bis[(pyrrolidin-1-yl) methyl] phenyl} ethan-1-one (3b)
The purification of the crude product which has been synthesized in the respective ratio of
1:2:2 of compound 1, formaldehyde and pyrrolidine was done using column chromatography with
EtOAc/MeOH (9:1) as eluent to yield 3b as dark red oily liquid (4.2 g; 86%). IR spectrum (
ν
max/cm−1):
δ, 400 MHz,
1302 (C–O), 1356 (C–N), 1597 (C=C), 1665 (C=O), 2963 (CH3, sp3). 1H NMR (ppm/
DMSO-d6): 1.76 (br s, 8H), 2.47 (s, 3H), 2.57 (br s, 8H), 3.77 (s, 4H), 7.69 (s, 2H). 13C NMR (100 MHz,
DMSO) ppm:
δ 23.66, 26.67, 53.54, 55.59, 123.68, 127.57, 128.98, 162.09, 196.56. EIMS, m/z (% rel.
intensity): 302 (14) [M+, C18H26N2O2], 231 (100), 216 (9), 188 (12), 159 (14), 147 (7), 133 (20), 119 (11),
84 (11), 70 (43), 55 (4).
3.1.5. 1-{4-Hydroxy-3-[(piperidin-1-yl) methyl] phenyl} ethan-1-one (4a)
The crude product of 4a was obtained from the reaction of the respective ratio 1:1.5:1.5
of compound
1
, formaldehyde, and piperidine. The obtained product was purified by ◦using
hexanes/EtOAc (6:4) as an eluent to yield 4a as colorless crystals (2.15 g, 58%), mp 82–83 C. IR
1
spectrum (
(ppm/
(s, 1H), 7.80 (d, J = 8.4 Hz, 1H), 11.41 (br s, 1H). 13C NMR (ppm/
ν
max/cm−1): 1256 (C–N), 1287 (C–O), 1594 (C=C), 1661 (C=O), 2946 (CH3, sp3). H NMR
δ
, 400 MHz, CDCl3): 1.67–1.52 (m, 6H), 2.53 (br s, 7H), 3.75 (s, 2H), 6.84 (d, J = 8.4 Hz, 1H), 7.68
, 100 MHz, CDCl3): 23.71, 25.6, 26.22,
δ
53.73, 61.51, 115.93, 121.06, 128.73, 129.35, 130.24, 163.32, 196.86. EIMS, m/z (% rel. intensity): 233 (10)
[M+, C14H19NO2], 149 (4), 133 (2), 106 (1), 98 (5), 84 (100), 77 (3), 56 (2).
3.1.6. 1-{4-Hydroxy-3,5-bis[(piperidin-1-yl) methyl] phenyl} ethan-1-one (4b)
The crude product resulted from the reaction of the respective ratio 1:2:2 of compound
formaldehyde, and piperidine was purified using hexanes/EtOAc (3:7) as eluent to yield 4b as
pale-yellow crystals mp 93–96 ◦C (5 g, 94%). IR spectrum ( max/cm−1): 1300 (C–O), 1349 (C–N), 1594
1,
ν